m+Medelevator.RU
← Поиск публикаций
Frontiers in endocrinology · 2026

Honey dressing for diabetic foot ulcers: a systematic review and meta-analysis of randomized controlled trials.

СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Yao Ling, Dai Jiezhi, Mei Shasha

Аннотация

BACKGROUND: To systematically evaluate the efficacy and safety of honey dressing compared to conventional dressings in the treatment of DFUs.

METHODS: We conducted a systematic review and meta-analysis following PRISMA guidelines. PubMed, BIOSIS, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), and Google Scholar internet were searched from inception to Jan 31, 2026 for RCTs comparing honey dressing with conventional dressings in DFU patients. Primary outcomes were complete wound healing rate and time to complete healing. Risk of bias was assessed using the Cochrane RoB 2.0 tool. The quality of evidence was graded through the Grading of Recommendations Assessment Development and Evaluations (GRADE) approach.

RESULTS: Sixteen RCTs involving 1423 participants were included. The sample sizes ranged from 23 to 348 participants. The follow-up duration varied from 4 to 24 weeks. Meta-analysis showed that honey dressing significantly improved the complete healing rate (OR 2.28, 95% CI 1.76 to 2.95) and reduced the time to complete healing (MD -4.38, 95% CI -8.06 to -0.71) compared to controls. According to the GRADE system, the overall quality of evidence for the outcomes of time to healing was rated as 'Low', and the quality of evidence for the outcomes of healing rate was rated as 'moderate'.

CONCLUSION: Honey dressing is a safe and more effective intervention for DFUs than conventional dressings, associated with significantly improved healing rates and faster healing time.

SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251244450, identifier CRD420251244450.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты